410 related articles for article (PubMed ID: 17505860)
1. The ability of existing questionnaires to measure symptom change after paracentesis for symptomatic ascites.
Easson AM; Bezjak A; Ross S; Wright JG
Ann Surg Oncol; 2007 Aug; 14(8):2348-57. PubMed ID: 17505860
[TBL] [Abstract][Full Text] [Related]
2. Malignant ascites symptom cluster in patients referred for paracentesis.
Husain A; Bezjak A; Easson A
Ann Surg Oncol; 2010 Feb; 17(2):461-9. PubMed ID: 19866240
[TBL] [Abstract][Full Text] [Related]
3. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
4. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.
Fitzsimmons D; Kahl S; Butturini G; van Wyk M; Bornman P; Bassi C; Malfertheiner P; George SL; Johnson CD
Am J Gastroenterol; 2005 Apr; 100(4):918-26. PubMed ID: 15784041
[TBL] [Abstract][Full Text] [Related]
5. New insights in symptom assessment: the Chinese Versions of the Memorial Symptom Assessment Scale Short Form (MSAS-SF) and the Condensed MSAS (CMSAS).
Lam WW; Law CC; Fu YT; Wong KH; Chang VT; Fielding R
J Pain Symptom Manage; 2008 Dec; 36(6):584-95. PubMed ID: 18434076
[TBL] [Abstract][Full Text] [Related]
6. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
[TBL] [Abstract][Full Text] [Related]
7. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
[TBL] [Abstract][Full Text] [Related]
8. The European Organization for Research and Treatment of Cancer core quality of life questionnaire (QLQ-C30 version 3.0 Turkish) in cancer patients receiving palliative radiotherapy.
Hiçsönmez A; Köse K; Andrieu MN; Güney Y; Kurtman C
Eur J Cancer Care (Engl); 2007 May; 16(3):251-7. PubMed ID: 17508945
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer.
Oñate-Ocaña LF; Alcántara-Pilar A; Vilar-Compte D; García-Hubard G; Rojas-Castillo E; Alvarado-Aguilar S; Carrillo JF; Blazeby JM; Aiello-Crocifoglio V
Ann Surg Oncol; 2009 Jan; 16(1):88-95. PubMed ID: 18979141
[TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal pressures and clinical parameters of total paracentesis for palliation of symptomatic ascites in ovarian cancer.
Gotlieb WH; Feldman B; Feldman-Moran O; Zmira N; Kreizer D; Segal Y; Elran E; Ben-Baruch G
Gynecol Oncol; 1998 Dec; 71(3):381-5. PubMed ID: 9887235
[TBL] [Abstract][Full Text] [Related]
11. The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires.
Jensen K; Bonde Jensen A; Grau C
Radiother Oncol; 2006 Mar; 78(3):298-305. PubMed ID: 16524633
[TBL] [Abstract][Full Text] [Related]
12. Quality of life of head and neck cancer patient: validation of the European organization for research and treatment of cancer QLQ-C30 and European organization for research and treatment of cancer QLQ-H&N 35 in Indian patients.
Chaukar DA; Das AK; Deshpande MS; Pai PS; Pathak KA; Chaturvedi P; Kakade AC; Hawaldar RW; D'Cruz AK
Indian J Cancer; 2005; 42(4):178-84. PubMed ID: 16391435
[TBL] [Abstract][Full Text] [Related]
13. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma.
Cocks K; Cohen D; Wisløff F; Sezer O; Lee S; Hippe E; Gimsing P; Turesson I; Hajek R; Smith A; Graham L; Phillips A; Stead M; Velikova G; Brown J;
Eur J Cancer; 2007 Jul; 43(11):1670-8. PubMed ID: 17574838
[TBL] [Abstract][Full Text] [Related]
14. Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy.
Ozturk A; Sarihan S; Ercan I; Karadag M
Am J Clin Oncol; 2009 Feb; 32(1):65-72. PubMed ID: 19194128
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the quality of life in chronic pancreatitis using Sf-12 and EORTC Qlq-C30 questionnaires.
Pezzilli R; Morselli-Labate AM; Fantini L; Campana D; Corinaldesi R
Dig Liver Dis; 2007 Dec; 39(12):1077-86. PubMed ID: 17692582
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.
Caissie A; Nguyen J; Chen E; Zhang L; Sahgal A; Clemons M; Kerba M; Arnalot PF; Danjoux C; Tsao M; Barnes E; Holden L; Danielson B; Chow E
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1238-45. PubMed ID: 22172909
[TBL] [Abstract][Full Text] [Related]
17. Evaluating cognitive, emotional, and physical fatigue domains in daily practice by single-item questions in patients with advanced cancer: a cross-sectional pragmatic study.
Strasser F; Müller-Käser I; Dietrich D
J Pain Symptom Manage; 2009 Oct; 38(4):505-14. PubMed ID: 19822275
[TBL] [Abstract][Full Text] [Related]
18. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases.
Chow E; Nguyen J; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Bottomley A;
Cancer; 2012 Mar; 118(5):1457-65. PubMed ID: 21837676
[TBL] [Abstract][Full Text] [Related]
19. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
[TBL] [Abstract][Full Text] [Related]
20. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
